Document is current
Any future updates will be listed below
-
Authors
Hendriks, Delilah https://orcid.org/0000-0003-1159-5946
Artegiani, Benedetta https://orcid.org/0000-0002-0904-4187
Margaritis, Thanasis https://orcid.org/0000-0003-4040-2015
Zoutendijk, Iris https://orcid.org/0000-0003-4620-2962
Chuva de Sousa Lopes, Susana
Clevers, Hans https://orcid.org/0000-0002-3077-5582
- License Information
-
More Information
Article History
Received: 2 November 2023
Accepted: 3 May 2024
First Online: 13 May 2024
Competing interests
: Near the end of this study, H.C. became head of Pharma, Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Basel, Switzerland. H.C. holds several patents on organoid technology. Their application numbers, followed by their publication numbers (if applicable), are as follows: PCT/NL2008/050543, WO2009/022907; PCT/NL2010/000017, WO2010/090513; PCT/IB2011/002167, WO2012/014076; PCT/IB2012/052950, WO2012/168930; PCT/EP2015/060815, WO2015/173425; PCT/EP2015/077990, WO2016/083613; PCT/EP2015/077988, WO2016/083612; PCT/EP2017/054797, WO2017/149025; PCT/EP2017/065101, WO2017/220586; PCT/EP2018/086716, n/a; and GB1819224.5, n/a. D.H., B.A. and H.C. are inventors on a filed patent related to hepatocyte organoids (PCT/NL2022/050641, n/a). The other authors declare no competing interests.
